 | • レポートコード：QFJ1-4450 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・リンパ腫治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、モノクローナル抗体療法、その他） ・リンパ腫治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他） ・リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Seattle Genetics、Merck、Bristol-Myers Squibb、Genmab AS、Pfizer、AstraZeneca、Takeda Pharmaceutical、Abbott、Eli Lilly、Johnson & Johnson、GSK） ・結論 |
Market Analysis and Insights: Global Lymphoma Treatment Market
The global Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymphoma Treatment market.
Global Lymphoma Treatment Scope and Market Size
Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Monoclonal Antibodies Therapy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Novartis
Seattle Genetics
Merck
Bristol-Myers Squibb
Genmab AS
Pfizer
AstraZeneca
Takeda Pharmaceutical
Abbott
Eli Lilly
Johnson & Johnson
GSK
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Monoclonal Antibodies Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lymphoma Treatment Market Perspective (2016-2027)
2.2 Lymphoma Treatment Growth Trends by Regions
2.2.1 Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Lymphoma Treatment Industry Dynamic
2.3.1 Lymphoma Treatment Market Trends
2.3.2 Lymphoma Treatment Market Drivers
2.3.3 Lymphoma Treatment Market Challenges
2.3.4 Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lymphoma Treatment Players by Revenue
3.1.1 Global Top Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymphoma Treatment Revenue
3.4 Global Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymphoma Treatment Revenue in 2020
3.5 Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lymphoma Treatment Breakdown Data by Type
4.1 Global Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Lymphoma Treatment Breakdown Data by Application
5.1 Global Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lymphoma Treatment Market Size (2016-2027)
6.2 North America Lymphoma Treatment Market Size by Type
6.2.1 North America Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Lymphoma Treatment Market Size by Application
6.3.1 North America Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Lymphoma Treatment Market Size by Country
6.4.1 North America Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Lymphoma Treatment Market Size by Type
7.2.1 Europe Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Lymphoma Treatment Market Size by Application
7.3.1 Europe Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Lymphoma Treatment Market Size by Country
7.4.1 Europe Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Lymphoma Treatment Market Size by Type
9.2.1 Latin America Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Lymphoma Treatment Market Size by Application
9.3.1 Latin America Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Lymphoma Treatment Market Size by Country
9.4.1 Latin America Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lymphoma Treatment Introduction
11.1.4 Roche Revenue in Lymphoma Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Lymphoma Treatment Introduction
11.2.4 Novartis Revenue in Lymphoma Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Seattle Genetics
11.3.1 Seattle Genetics Company Details
11.3.2 Seattle Genetics Business Overview
11.3.3 Seattle Genetics Lymphoma Treatment Introduction
11.3.4 Seattle Genetics Revenue in Lymphoma Treatment Business (2016-2021)
11.3.5 Seattle Genetics Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Lymphoma Treatment Introduction
11.4.4 Merck Revenue in Lymphoma Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Lymphoma Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Lymphoma Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Genmab AS
11.6.1 Genmab AS Company Details
11.6.2 Genmab AS Business Overview
11.6.3 Genmab AS Lymphoma Treatment Introduction
11.6.4 Genmab AS Revenue in Lymphoma Treatment Business (2016-2021)
11.6.5 Genmab AS Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Lymphoma Treatment Introduction
11.7.4 Pfizer Revenue in Lymphoma Treatment Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Lymphoma Treatment Introduction
11.8.4 AstraZeneca Revenue in Lymphoma Treatment Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Lymphoma Treatment Introduction
11.9.4 Takeda Pharmaceutical Revenue in Lymphoma Treatment Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Lymphoma Treatment Introduction
11.10.4 Abbott Revenue in Lymphoma Treatment Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Lymphoma Treatment Introduction
11.11.4 Eli Lilly Revenue in Lymphoma Treatment Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Lymphoma Treatment Introduction
11.12.4 Johnson & Johnson Revenue in Lymphoma Treatment Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development
11.13 GSK
11.13.1 GSK Company Details
11.13.2 GSK Business Overview
11.13.3 GSK Lymphoma Treatment Introduction
11.13.4 GSK Revenue in Lymphoma Treatment Business (2016-2021)
11.13.5 GSK Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Monoclonal Antibodies Therapy
Table 5. Key Players of Others
Table 6. Global Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lymphoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lymphoma Treatment Market Share by Regions (2022-2027)
Table 12. Lymphoma Treatment Market Trends
Table 13. Lymphoma Treatment Market Drivers
Table 14. Lymphoma Treatment Market Challenges
Table 15. Lymphoma Treatment Market Restraints
Table 16. Global Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lymphoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Treatment as of 2020)
Table 19. Ranking of Global Top Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lymphoma Treatment Product Solution and Service
Table 23. Date of Enter into Lymphoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Lymphoma Treatment Product
Table 66. Roche Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Lymphoma Treatment Product
Table 71. Novartis Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Seattle Genetics Company Details
Table 74. Seattle Genetics Business Overview
Table 75. Seattle Genetics Lymphoma Treatment Product
Table 76. Seattle Genetics Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Seattle Genetics Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Lymphoma Treatment Product
Table 81. Merck Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Lymphoma Treatment Product
Table 86. Bristol-Myers Squibb Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Genmab AS Company Details
Table 89. Genmab AS Business Overview
Table 90. Genmab AS Lymphoma Treatment Product
Table 91. Genmab AS Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Genmab AS Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Lymphoma Treatment Product
Table 96. Pfizer Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Takeda Pharmaceutical Company Details
Table 103. Takeda Pharmaceutical Business Overview
Table 104. Takeda Pharmaceutical Lymphoma Treatment Product
Table 105. Takeda Pharmaceutical Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Takeda Pharmaceutical Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Lymphoma Treatment Product
Table 110. Abbott Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. Eli Lilly Company Details
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Lymphoma Treatment Product
Table 115. Eli Lilly Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Eli Lilly Recent Development
Table 117. Johnson & Johnson Company Details
Table 118. Johnson & Johnson Business Overview
Table 119. Johnson & Johnson Lymphoma Treatment Product
Table 120. Johnson & Johnson Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 121. Johnson & Johnson Recent Development
Table 122. GSK Company Details
Table 123. GSK Business Overview
Table 124. GSK Lymphoma Treatment Product
Table 125. GSK Revenue in Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 126. GSK Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Monoclonal Antibodies Therapy Features
Figure 5. Others Features
Figure 6. Global Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Lymphoma Treatment Report Years Considered
Figure 12. Global Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Lymphoma Treatment Market Share by Players in 2020
Figure 17. Global Top Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Lymphoma Treatment Revenue in 2020
Figure 19. Global Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Lymphoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Lymphoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Lymphoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Lymphoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Lymphoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Lymphoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Lymphoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Lymphoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Lymphoma Treatment Market Share by Region (2016-2027)
Figure 41. China Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Lymphoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Lymphoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Lymphoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Lymphoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Lymphoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Lymphoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 62. Seattle Genetics Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 65. Genmab AS Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 68. Takeda Pharmaceutical Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 69. Abbott Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 71. Johnson & Johnson Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 72. GSK Revenue Growth Rate in Lymphoma Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market The global Peripheral T-Cell Lymphoma (PTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
- 世界の皮膚細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Cell Lymphoma Treatment Market The global Cutaneous Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…